Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 7(1): e30007, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22238689

RESUMEN

Beta-amyloid (Aß) peptides are considered to play a major role in the pathogenesis of Alzheimer's disease (AD) and molecules that can prevent pathways of Aß toxicity may be potential therapeutic agents for treatment of AD. We have previously reported that NK-4, a cyanine photosensitizing dye, displays neurotrophic and antioxidant activities. In this study, we report the effects of NK-4 on the toxicity of Aß and on cognitive function and Aß concentration in a transgenic mouse model of AD (Tg2576). In vitro, NK-4 effectively protected neuronal cells from toxicity induced by Aß. In addition, it displayed profound inhibitory activities on Aß fibril formation. In vivo, Tg2576 mice received an intraperitoneal injection at 100 or 500 µg/kg of NK-4 once a day, five times a week for 9 months. Administration of NK-4 to the mice attenuated impairment of recognition memory, associative memory, and learning ability, as assessed by a novel object recognition test, a passive avoidance test, and a water maze test, respectively. NK-4 decreased the brain Aß concentration while increasing the plasma amyloid level in a dose-dependent manner. NK-4 also improved memory impairments of ICR mice induced by direct intracerebroventricular administration of Aß. These lines of evidence suggest that NK-4 may affect multiple pathways of amyloid pathogenesis and could be useful for treatment of AD.


Asunto(s)
Enfermedad de Alzheimer/patología , Fármacos Fotosensibilizantes/farmacología , Quinolinas/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/psicología , Animales , Carbocianinas , Fármacos del Sistema Nervioso Central/farmacología , Fármacos del Sistema Nervioso Central/uso terapéutico , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Femenino , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Endogámicos ICR , Ratones Transgénicos , Células PC12 , Fármacos Fotosensibilizantes/uso terapéutico , Quinolinas/uso terapéutico , Ratas , Reconocimiento en Psicología/efectos de los fármacos , Reconocimiento en Psicología/fisiología , Natación/fisiología , Natación/psicología
2.
PLoS One ; 6(2): e17137, 2011 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-21347252

RESUMEN

BACKGROUND: Neurotrophic factors may be future therapeutic agents for neurodegenerative disease. In the screening of biologically active molecules for neurotrophic potency, we found that a photosensitizing cyanine dye, NK-4, had remarkable neurotrophic activities and was a potent radical scavenger. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we evaluated the effect of NK-4 on the protection of neurons against oxidative damage and investigated the associated intracellular signaling pathways. Subsequently, we evaluated the effect of NK-4 in an animal model of neurodegeneration. In vitro, NK-4 showed dose-dependent protection of PC12 cells from toxicity induced by oxidative stress caused by hydrogen peroxide (H(2)O(2)) or 6-hydroxydopamine (6-OHDA). Comparison of extracellular signal-regulated kinase signaling pathways between treatment with NK-4 and nerve growth factor (NGF) using K252a, an inhibitor of the NGF receptor TrkA, revealed that NK-4 activity occurs independently of NGF receptors. LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor, blocked the protective effect of NK-4, and NK-4 caused activation of Akt/protein kinase B, a downstream effector of PI3K. These results suggest that the neuroprotective effects of NK-4 are mediated by the PI3K-Akt signaling pathway. NK-4 treatment also attenuated stress-induced activation of SAPK/JNK, which suggests that NK-4 activates a survival signaling pathway and inhibits stress-activated apoptotic pathways independently of the TrkA receptor in neuronal cells. In vivo, administration of NK-4 improved motor coordination in genetic ataxic hamsters, as assessed by rota-rod testing. Histological analysis showed that cerebellar atrophy was significantly attenuated by NK-4 treatment. Notably, the Purkinje cell count in the treated group was threefold higher than that in the vehicle group. CONCLUSIONS/SIGNIFICANCE: These results suggest that NK-4 is a potential agent for therapy for neurodegenerative disorders based on the activation of survival signaling pathways.


Asunto(s)
Carbocianinas/farmacología , Ataxia Cerebelosa/tratamiento farmacológico , Colorantes/farmacología , Enfermedades Neurodegenerativas/tratamiento farmacológico , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Desempeño Psicomotor/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Animales , Atrofia/tratamiento farmacológico , Carbocianinas/uso terapéutico , Proliferación Celular/efectos de los fármacos , Ataxia Cerebelosa/metabolismo , Ataxia Cerebelosa/patología , Ataxia Cerebelosa/fisiopatología , Colorantes/uso terapéutico , Cricetinae , Modelos Animales de Enfermedad , Femenino , Espacio Intracelular/efectos de los fármacos , Espacio Intracelular/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Masculino , Mutación , Neuritas/efectos de los fármacos , Neuritas/metabolismo , Enfermedades Neurodegenerativas/metabolismo , Enfermedades Neurodegenerativas/patología , Enfermedades Neurodegenerativas/fisiopatología , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Neurotoxinas/toxicidad , Estrés Oxidativo/efectos de los fármacos , Células PC12 , Células de Purkinje/efectos de los fármacos , Células de Purkinje/metabolismo , Células de Purkinje/patología , Ratas , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
3.
Biol Pharm Bull ; 33(11): 1872-7, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21048314

RESUMEN

Some photosensitizing cyanine dyes act on the immune system to enhance the phagocytic capacity of macrophages. In this study, we examined whether these dyes have neurotrophin-like activities and neuroprotective effects in vitro and in vivo. By screening more than 250 cyanine dyes, we found that NK-4 and NK-150, which belong to a group of pentamethine trinuclear cyanine dyes, significantly potentiated nerve growth factor (NGF)-primed neurite outgrowth of PC12HS cells in nanomolar to micromolar concentrations. Both NK-4 and NK-150 showed a remarkable hydroxyl radical-scavenging activity using an in vitro electron spin resonance (ESR)-based technique. They also effectively scavenged peroxy radicals, and in addition, NK-4 acted on superoxides to a similar extent as ascorbate. In vivo, NK-4 and NK-150 prevented cerebral ischemic injury induced by 2 h middle cerebral artery occlusion (MCAO) and 24 h reperfusion in rats. Dyes were intravenously administrated twice 1 h after the occlusion and immediately after the start of reperfusion. NK-4 and NK-150 (100 µg/kg) reduced cerebral infarct volumes by 57.0% and 46.0%, respectively. Those dyes also decreased brain swelling in the ischemic semispheres. As a result, administration of NK-4 and NK-150 provided substantial improvements in MCAO-induced neurological deficits in a dose-dependent manner. These results suggest that NK-4 and NK-150 effectively prevented ischemia-induced brain injury through their potent neurotrophin-like activity as well as antioxidative activity.


Asunto(s)
Antioxidantes/uso terapéutico , Isquemia Encefálica/prevención & control , Carbocianinas/uso terapéutico , Infarto Cerebral/prevención & control , Fármacos Neuroprotectores/uso terapéutico , Quinolinas/uso terapéutico , Especies Reactivas de Oxígeno/metabolismo , Daño por Reperfusión/prevención & control , Animales , Antioxidantes/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Isquemia Encefálica/metabolismo , Carbocianinas/farmacología , Línea Celular , Infarto Cerebral/metabolismo , Relación Dosis-Respuesta a Droga , Edema/prevención & control , Espectroscopía de Resonancia por Spin del Electrón , Infarto de la Arteria Cerebral Media , Masculino , Factor de Crecimiento Nervioso/metabolismo , Neuritas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Quinolinas/farmacología , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/metabolismo
4.
J Interferon Cytokine Res ; 28(6): 359-66, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18593331

RESUMEN

In the present study, we describe the generation of a series of anti-interferon-alpha8 (IFN-alpha8)-specific monoclonal antibodies (mAbs), their characterization, and the establishment of a sandwich enzyme-linked immunosorbent assay (ELISA) system for human IFN-alpha8. The sandwich ELISA system is highly sensitive to human natural IFN-alpha8 (nIFN-alpha8), with a minimum detection limit of 50 pg/mL, which did not cross-react with the other IFN preparations and several cytokines tested. Using this ELISA system, pharmacokinetic properties of an IFN-alpha preparation administered in mice were examined. We found that IFN-alpha8 has higher vascular permeability and stability than IFN-alpha2 in the circulation. These results suggest that this ELISA would be very useful for determination of IFN-alpha8 protein concentrations in various experimental samples and also of pharmacokinetic properties of IFN-alpha preparations in human.


Asunto(s)
Anticuerpos Monoclonales , Ensayo de Inmunoadsorción Enzimática , Interferones/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/aislamiento & purificación , Anticuerpos Monoclonales/farmacocinética , Permeabilidad Capilar , Reacciones Cruzadas , Epítopos , Femenino , Humanos , Hibridomas , Interferón-alfa , Interferones/farmacocinética , Ratones , Ratones Endogámicos BALB C , Ratas , Ratas Endogámicas BN , Sensibilidad y Especificidad
5.
In Vivo ; 21(1): 25-32, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17354610

RESUMEN

BACKGROUND: Endogenous tumor necrosis factor-alpha (TNF-alpha) has a beneficial effect as an activation mediator of host defense against infection by the fungus Candida albicans (C. albicans). However, it is unclear whether exogenous TNF-alpha has a beneficial or detrimental effect against Candida. MATERIALS AND METHODS: The direct effect of TNF-alpha on CO2-induced morphological transformation of C. albicans blastoconidia was examined in vitro and the effect of TNF-alpha was determined in a mouse model of oral candidiasis. RESULTS: TNF-alpha suppressed hyphal formation from C. albicans blastoconidia directly and dose-dependently, whereas it did not affect the fungal budding rate at concentrations ranging from 0.01 to 10 microg/ml. In vivo, the oral administration of TNF-alpha significantly reduced the C. albicans CFU in tongue tissues of treated mice. Histopathologically, there was a decrease in the number and size of C. albicans fungi in the tongue tissues. CONCLUSION: Since orally administered TNF-alpha suppressed fungal burden in the tongue tissue without significant detrimental effects, TNF-alpha has potential as a therapeutic agent against Candida.


Asunto(s)
Antifúngicos/uso terapéutico , Candida albicans/efectos de los fármacos , Candidiasis Bucal/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/uso terapéutico , Animales , Antifúngicos/farmacología , Candida albicans/crecimiento & desarrollo , Candida albicans/fisiología , Candidiasis Bucal/microbiología , Dióxido de Carbono/farmacología , Modelos Animales de Enfermedad , Femenino , Humanos , Ratones , Ratones Endogámicos ICR , Lengua/efectos de los fármacos , Lengua/microbiología , Factor de Necrosis Tumoral alfa/farmacología
6.
Comp Biochem Physiol C Toxicol Pharmacol ; 143(4): 484-91, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16807122

RESUMEN

Mammalian hibernators are considered a natural model for resistance to ischemia-reperfusion injuries, and protective mechanisms against oxidative stress evoked by repeated hibernation-arousal cycles in these animals are increasingly the focus of experimental investigation. Here we show that extracellular catalase activity provides protection against oxidative stress during arousal from hibernation in Syrian hamster. To examine the serum antioxidant defense system, we first assessed the hibernation-arousal state-dependent change in serum attenuation of cytotoxicity induced by hydrogen peroxide. Serum obtained from hamsters during arousal from hibernation at a rectal temperature of 32 degrees C, concomitant with the period of increased oxidative stress, attenuated the cytotoxicity four-fold more effectively than serum from cenothermic control hamsters. Serum catalase activity significantly increased during arousal, whereas glutathione peroxidase activity decreased by 50%, compared with cenothermic controls. The cytoprotective effect of purified catalase at the concentration found in serum was also confirmed in a hydrogen peroxide-induced cytotoxicity model. Moreover, inhibition of catalase by aminotriazole led to an 80% loss of serum hydrogen peroxide scavenging activity. These results suggest that extracellular catalase is effective for protecting hibernators from oxidative stress evoked by arousal from hibernation.


Asunto(s)
Antioxidantes/metabolismo , Nivel de Alerta/fisiología , Catalasa/metabolismo , Animales , Cricetinae , Femenino , Glutatión/sangre , Glutatión Peroxidasa/sangre , Glutatión Reductasa/sangre , Hibernación/fisiología , Peróxido de Hidrógeno/toxicidad , Mesocricetus , Células PC12 , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA